Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.

Kazuko Kobayashi1, Makoto Kishi, Tatsuya Atsumi

  • 1Department of Cell Chemistry, Okayama University Graduate School of Medicine and Dentistry, Japan.

Journal of Lipid Research
|February 4, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HTLV-1-Infected CD4<sup>+</sup> T Cells Drive Spontaneous Lymphoproliferation and Virus-Specific CD8<sup>+</sup> Cytotoxic T Lymphocyte Expansion in HAM/TSP.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Biallelic variants in FAT3 cause axonal neuropathy with multisystem neurodevelopmental features.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

The regulatory roles of Beta-2 glycoprotein I (β2GPI) in thrombosis and hemostasis and abnormal disease conditions developed by autoantibodies against β2GPI.

Autoimmunity reviews·2026
Same author

Retraction notice to "IDF23-0574 Role of urinary HO, 8-iso-PGF2a, and serum oxLDL/ß2GP1 complex in the diabetic kidney disease." [PLoS One 17(4) (2022) e0263113].

Diabetes research and clinical practice·2025
Same author

HTLV-1-Specific CTL Accumulation in CSF Contributes to Neuroinflammation in HTLV-1-Associated Myelopathy.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Clinical Characteristics of Parkinsonism in HTLV-1-Associated Myelopathy.

Annals of clinical and translational neurology·2025

Beta2-glycoprotein I (beta2-GPI) binds to oxidized LDL (oxLDL), forming stable complexes. High levels of these beta2-GPI-oxLDL complexes in serum are linked to arterial thrombosis in antiphospholipid syndrome (APS).

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Lipid Metabolism

Background:

  • Beta2-glycoprotein I (beta2-GPI) is a key antigen in antiphospholipid syndrome (APS).
  • Previous studies showed beta2-GPI binds to Cu2+-oxidized LDL (oxLDL), specifically to omega-carboxylated 7-ketocholesteryl esters.

Purpose of the Study:

  • To investigate the formation and clinical significance of beta2-GPI-oxLDL complexes in APS patients.
  • To determine the structural requirements for beta2-GPI binding to oxLDL ligands.

Main Methods:

  • Detection of beta2-GPI-oxLDL complexes in patient sera.
  • Analysis of the chemical structure of beta2-GPI ligands.
  • In vitro studies on complex formation and stability.
  • Correlation analysis between complex levels, autoantibodies, and clinical outcomes (arterial thrombosis).

Related Experiment Videos

Main Results:

  • Oxidized LDL forms stable, nondissociable complexes with beta2-GPI in serum.
  • High serum levels of these complexes correlate with arterial thrombosis in APS.
  • Specific chemical features (ketone and carboxyl functions) are essential for beta2-GPI binding.
  • Stable beta2-GPI-oxLDL complexes and IgG autoantibodies against them are strongly associated with arterial thrombosis and autoimmune-mediated atherogenesis.

Conclusions:

  • Beta2-glycoprotein I-oxidized LDL complexes are stable autoantigens in APS.
  • These complexes and associated autoantibodies are significant biomarkers for arterial thrombosis risk.
  • The findings highlight the role of beta2-GPI-oxLDL complexes in autoimmune-mediated atherogenesis.